RGLS - Regulus Therapeutics Inc
IEX Last Trade
1.68
0.030 1.786%
Share volume: 162,153
Last Updated: Fri 30 Aug 2024 09:59:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.65
0.03
1.82%
Summary score
33%
Profitability
43%
Dept financing
21%
Liquidity
37%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
174.4%
Return on assets
-21.94%
Return on sales
0%
Return on invested capital
-233.74%
Total debt ratio
73.47%
Debt ratio change over timeo
0.25%
Current Ratio
2.86%
Quick Ratio
4.77%
Cash Position Ratio
0.89%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
1223.85%
Return on assets
-20.31%
Return on sales
0%
Return on invested capital
40.1%
Total debt ratio
76.43%
Debt ratio change over timeo
1.14%
Current Ratio
1.14%
Quick Ratio
0%
Cash Position Ratio
1.08%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-80.93%
Return on assets
-21.81%
Return on sales
0%
Return on invested capital
43.79%
Total debt ratio
71.18%
Debt ratio change over time
0.73%
Current Ratio
1.18%
Quick Ratio
0%
Cash Position Ratio
1.12%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
606%
Return on assets
-130.06%
Return on sales
0%
Return on invested capital
-26.89%
Total debt ratio
24.58%
Debt ratio change over time
0.25%
Current Ratio
0.47%
Quick Ratio
-1.09%
Cash Position Ratio
0.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RGLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 174.4% | -3.05% | 11.55% | 6.27% |
| Return on assets | -21.94% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -233.74% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 46% | 59% | 71% |
| Total debt ratio | 73.47% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | 0.25% | 6.09% | 6.03% | 1.53% |
| Dept financing | 19% | 50% | 43% | 14% |
| Current Ratio | 1.14% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.08% | 1.48% | 0.76% | 1.49% |
| Liquididy | 62% | 32% | 54% | 66% |
| Short-term ratios | RGLS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1223.85% | -25.62% | 17.94% | 7.14% |
| Return on assets | -20.31% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 40.1% | 8.14% | 7.17% | 18.16% |
| Profitability | 50% | 43% | 49% | 59% |
| Total debt ratio | 76.43% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | 1.14% | -23.44% | 9.66% | 0.6% |
| Dept financing | 21% | 25% | 45% | 8% |
| Current Ratio | 1.14% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.08% | 1.48% | 0.76% | 1.49% |
| Liquididy | 26% | 57% | 42% | 75% |